Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.
- DOI
- 10.1016/j.xcrm.2026.103000
- Published
- 2026 Sep 15
- Container
- Cell reports. Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.xcrm.2026.103000,
title = {Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.},
author = {Hegelmaier T and Motte J and Walther D and Feist E and Duscha A and Desel C and Pappa V and Böttcher M and Voigt M and Sgodzai M and Al-Dubai M and Schroers R and Borie D and Schett G and Mougiakakos D and Gold R and Haghikia A},
year = {2026},
journal = {Cell reports. Medicine},
doi = {10.1016/j.xcrm.2026.103000},
url = {https://doi.org/10.1016/j.xcrm.2026.103000}
}RIS
TY - JOUR TI - Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series. AU - Hegelmaier T AU - Motte J AU - Walther D AU - Feist E AU - Duscha A AU - Desel C AU - Pappa V AU - Böttcher M AU - Voigt M AU - Sgodzai M AU - Al-Dubai M AU - Schroers R AU - Borie D AU - Schett G AU - Mougiakakos D AU - Gold R AU - Haghikia A PY - 2026 JO - Cell reports. Medicine DO - 10.1016/j.xcrm.2026.103000 UR - https://doi.org/10.1016/j.xcrm.2026.103000 ER -
APA
T, H., J, M., D, W., E, F., A, D., C, D., V, P., M, B., M, V., M, S., M, A., R, S., D, B., G, S., D, M., R, G., & A, H. (2026). Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.. Cell reports. Medicine. https://doi.org/10.1016/j.xcrm.2026.103000
Source records
- pubmed · retrieved 2026-09-25T15:24:11.659Z